Sphingosine 1-phosphate induces arachidonic acid mobilization in A549 human lung adenocarcinoma cells

Biochim Biophys Acta. 2000 Jan 3;1483(1):154-60. doi: 10.1016/s1388-1981(99)00183-3.

Abstract

In the present paper, the effect of sphingosine 1-phosphate (Sph-1-P) on arachidonic acid mobilization in A549 human lung adenocarcinoma cells was investigated. Sph-1-P provoked a rapid and relevant release of arachidonic acid which was similar to that elicited by bradykinin, well-known pro-inflammatory agonist. The Sph-1-P-induced release of arachidonic acid involved Ca(2+)-independent phospholipase A(2) (iPLA2) activity, as suggested by the dose-dependent inhibition exerted by the rather specific inhibitor bromoenol lactone. The Sph-1-P-induced release of arachidonic acid was pertussis toxin-sensitive, pointing at a receptor-mediated mechanism, which involves heterotrimeric Gi proteins. The action of Sph-1-P was totally dependent on protein kinase C (PKC) catalytic activity and seemed to involve agonist-stimulated phospholipase D (PLD) activity. This study represents the first evidence for Sph-1-P-induced release of arachidonic acid which occurs through a specific signaling pathway involving Gi protein-coupled receptor(s), PKC, PLD and iPLA2 activities.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma
  • Arachidonic Acid / metabolism*
  • Enzyme Inhibitors / pharmacology
  • Humans
  • Lipid Mobilization / drug effects
  • Lung Neoplasms
  • Lysophospholipids*
  • Phosphatidic Acids / analysis
  • Phospholipase D / metabolism
  • Phospholipases A / metabolism
  • Protein Kinase C / metabolism
  • Sphingosine / analogs & derivatives*
  • Sphingosine / pharmacology
  • Tritium
  • Tumor Cells, Cultured

Substances

  • Enzyme Inhibitors
  • Lysophospholipids
  • Phosphatidic Acids
  • Tritium
  • sphingosine 1-phosphate
  • Arachidonic Acid
  • Protein Kinase C
  • Phospholipases A
  • Phospholipase D
  • Sphingosine

Grants and funding